Structural Formula (371e1085 3e61 4192 Ab8b 883ba90639f2 01)
Alosetron Tablet
Product Images NDC 63629-2518
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Alosetron (NDC 63629-2518). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (371e1085 3e61 4192 Ab8b 883ba90639f2 02)
The text appears to be a table showing the percentage of patients in different studies, along with the number of patients who were given a placebo or a medication called Alosetron Tablets 1mg B..D. The studies are identified as either "Studies 1&2" or "Studies 3&4".*
Label (Lbl636292518)
This is a description of Alosetron tablets, USP, containing 1 mg Alosetron Hydrochloride commonly known as NILD. The recommended storage temperature is between 20-25°C and the tablets should be kept away from children in a tight, light-resistant container with child-resistant closure. The tablets are dispensed in packs containing 30 tablets and the NDC is 63629-2518-1.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
